CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Avant Diagnostics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Avant Diagnostics, Inc.
1050 30th Street NW
Suite 107
Phone: (732) 410-9810p:732 410-9810 Washington, D.C.  20007-3822  United States Fax: (661) 377-1848f:661 377-1848
This company is no longer actively traded on any major stock exchange.
Business Summary
Avant Diagnostics, Inc., is a healthcare data generating technology company. The company focuses on biomarker tests that are being planned or developed in multiple areas of oncology. The Company through TheraLink assays provides personalized medicine data for breast cancer. It develops phospho-proteomic technologies for measuring the activation status of key signaling pathways, with applications across multiple cancer types including breast, colorectal and pancreatic that are instrumental in the development of companion diagnostics for molecular-targeted therapies. Theralink provides actionable information that enables community physicians and clinical trial investigators to make treatment decisions for their patients.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20189/30/2018YesYes-Yes-

Industries
SIC Code Description
8731 Commercial physical and biological research
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JeffreyBusch 57 5/25/2018 5/25/2018
President, Chief Executive Officer, Director MickRuxin 5/25/2018 5/25/2018
Interim Chief Financial Officer ScottVanderMeer 5/25/2018 12/11/2017
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Theranostics Health, Inc. 217 Perry Parkway, Suite 8 Gaithersburg MD United States

Business Names
Business Name
Amarantus Diagnostics, Inc.
American Liberty Petroleum Corp.
Avant Diagnostics, Inc.
5 additional Business Names available in full report.

General Information
Outstanding Shares: 336,957,722 (As of 2/20/2019)
Shareholders: 8
Stock Exchange: OTC
Federal Tax Id: 980599151
Fax Number: (661) 377-1848


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023